SKI Market

Indian Indices

Sensex

78,210.67 644.51
( 0.83%)

Global Indices

Nasdaq

47,737.88 215.33
(0.45%)

Dow Jones

6,814.47 53.45
(0.79%)

Hang Seng

52,808.52 -2,812.32
(-5.06%)

Nikkei 225

10,249.54 -35.21
(-0.34%)

Forex

USD-INR

91.85 0.10
(0.11%)

EUR-INR

106.60 0.13
(0.12%)

GBP-INR

123.04 0.62
(0.51%)

JPY-INR

0.58 0.00
(-0.25%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Marksans Pharma Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

524404

INE750C01026

32.9918134

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

MARKSANS

30.97

7633.54

EPS(TTM)

Face Value()

Div & Yield %

5.44

0.47

Back

tmt (i) ltd

PVV Infra consolidated net profit rises 3408.33% in the December 2025 quarter

Feb 10,2026

Net profit of PVV Infra rose 3408.33% to Rs 4.21 crore in the quarter ended December 2025 as against Rs 0.12 crore during the previous quarter ended December 2024. Sales rose 96.85% to Rs 16.24 crore in the quarter ended December 2025 as against Rs 8.25 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	16.24	8.25	97
OPM %	30.48	1.70	-
PBDT	4.95	0.14	3436
PBT	4.95	0.14	3436
NP	4.21	0.12	3408

78,210.67 644.51 ( 0.83%)

47,737.88 215.33 (0.45%)

6,814.47 53.45 (0.79%)

52,808.52 -2,812.32 (-5.06%)

10,249.54 -35.21 (-0.34%)

91.85 0.10 (0.11%)

106.60 0.13 (0.12%)

123.04 0.62 (0.51%)

0.58 0.00 (-0.25%)